Algol Group structure
The Group comprises six business units: Algol Chemicals, Algol Diagnostics, Algol Technics, Algol Trehab, Histolab Products and Suomen Unipol (ownership 74 %).
The Board of Directors of the parent company Algol Oy is responsible for the governance of the entire Group and the appropriate organisation of its operations. The Board focuses on issues related to its ownership strategy, financing and the use of Group resources.
The parent company is also responsible for the Group’s shared functions. These include, for example, financial administration, property management, ICT, corporate responsibility, the Group’s internal and external communications, and the Algol brand.
The implementation of good corporate governance at Algol is supported by the Group’s Code of Business Conduct.
Ownership
Algol is a Finnish family business. The Bargum family owns 100% of all company shares. The three largest shareholders own 98% of the shares.
Group management
Executive Board
Alexander Bargum
Managing Director,Algol Oy, Chairman
Joakim Flinck
CFO, Algol Oy
Eija Holmström
Director, HR, Comms & Corp. Responsibility, Algol Oy
Olof Jenefeldt
Managing Director, Histolab Products AB
Juha Jokinen
Managing Director, Algol Chemicals Oy
Sauli Mäntylä
Managing Director, Algol Technics Oy
Arto Peterzens
ICT Director, Algol Oy
Johan Wulff
Managing Director, Algol Diagnostics Oy, Algol Trehab Oy
Supervisory Board
Martin Granholm
M.Sc(Eng.), D.Sc.(Tech.), h.c, Chairman
Alexander Bargum
LL.M.
Johannes Bargum
QBA
Magnus Bargum
M.Sc.(Econ.), D.Sc.(Econ.), h.c.
Kaj Hedvall
D.Sc.(Econ.), M.Sc.(Tech.)
Kenneth Nystén
B.Sc. (Econ.), MBA
